SCHEMBL23337007

SCHEMBL23337007

CC1OC(COS(=O)(=O)O)C(OC2OC(C(=O)O)C(O)C(O)C2OS(=O)(=O)O)C(O)C1NS(=O)(=O)O

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ F10 P00742 4/20 0.64
▸ BDNF P23560 3/20 0.46
▸ PTN P21246 2/20 0.46
▸ MDK P21741 2/20 0.46
▸ SERPINC1 P01008 2/20 0.45
▸ CXCL12 P48061 3/20 0.41
▸ CCL2 P13500 2/20 0.41
▸ CXCL10 P02778 1/20 0.41
▸ CXCL8 P10145 1/20 0.41
▸ CCL5 P13501 1/20 0.41
▸ BMP2 P12643 2/20 0.41
▸ VEGFA P15692 2/20 0.41
▸ SHH Q15465 2/20 0.41
▸ F2 P00734 1/20 0.40
▸ PF4 P02776 2/20 0.39
▸ IFNG P01579 1/20 0.39
▸ SELP P16109 1/20 0.39
▸ BMP6 P22004 1/20 0.39
▸ CCL11 P51671 1/20 0.39
▸ WNT3A P56704 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14706300 0.93 F10 (0.70) F10BDNFPTNMDKSERPINC1
SCHEMBL14252707 0.93 F10 (0.70) F10BDNFPTNMDKSERPINC1
SCHEMBL13311345 0.90 F10 (0.64) F10BDNFPTNMDKSERPINC1
SCHEMBL14670002 0.90 F10 (0.64) F10BDNFPTNMDKSERPINC1
SCHEMBL4593793 0.90 F10 (0.64) F10BDNFPTNMDKSERPINC1
SCHEMBL29308178 0.90 F10 (0.79) F10BDNFPTNMDKSERPINC1
SCHEMBL23135895 0.89 F10 (0.62) F10BDNFPTNMDKSERPINC1
SCHEMBL16502382 0.88 F10 (0.76) F10BDNFPTNMDKSERPINC1
SCHEMBL10157440 0.84 F10 (0.81) F10BDNFPTNMDKSERPINC1
SCHEMBL15199336 0.84 F10 (0.81) F10BDNFPTNMDKSERPINC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240219372-A1 ANALYTICAL METHOD FOR GLYCOSAMINOGLYCANS JCR PHARMACEUTICALS CO., LTD. (JP) 2024-07-04 — — US disclosed
US-20210132040-A1 ANALYTICAL METHOD FOR GLYCOSAMINOGLYCANS JCR PHARMACEUTICALS CO., LTD. (JP) 2021-05-06 — — US disclosed
Send feedback